Condition: Epilepsy · Seizures, Epileptic · Sponsor: Supernus Pharmaceuticals, Inc.
This study will evaluate the safety and tolerability of SPN-817 in adults with treatment resistant seizures
This description comes directly from the study's public registry record.
Supernus Clinical Trials · 240-403-5838 · clinicaltrials@supernus.com
Navid Saiedi, MS · 240-403-5328 · nsaeidi@supernus.com
Always discuss trial participation with your own doctor first.
| Green Leaf Clinical Trials, LLC | Jacksonville, Florida, United States | Recruiting |
| Visionary Investigators Network | Miami, Florida, United States | Recruiting |
| Prince of Wales Hospital | Randwick, New South Wales, Australia | Recruiting |
| Royal Prince Alfred Hospital | Sydney, New South Wales, Australia | Completed |
| Westmead Hospital | Sydney, New South Wales, Australia | Completed |
| Royal Brisbane and Women's Hospital | Brisbane, Queensland, Australia | Recruiting |
| Box Hill Hospital | Box Hill, Victoria, Australia | Recruiting |
| The Austin Hospital | Heidelberg, Victoria, Australia | Recruiting |
| The Alfred Hospital | Melbourne, Victoria, Australia | Recruiting |
| The Royal Melbourne Hospital | Parkville, Victoria, Australia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05518578